CVS Health Corporation $CVS Stock: Crossmark Global Holdings Inc. Raises Stake

Crossmark Global Holdings Inc. lifted its position in CVS Health Corporation (NYSE:CVS) by 11.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 440,645 shares of the pharmacy operator’s stock after buying an additional 44,828 shares during the period. Crossmark Global Holdings Inc.’s holdings in CVS Health were worth $37,759,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of the company. Guardian Partners Inc. increased its stake in CVS Health by 12.4% in the 3rd quarter. Guardian Partners Inc. now owns 5,196 shares of the pharmacy operator’s stock worth $445,000 after buying an additional 574 shares in the last quarter. Strengthening Families & Communities LLC lifted its position in shares of CVS Health by 8.3% in the third quarter. Strengthening Families & Communities LLC now owns 32,998 shares of the pharmacy operator’s stock valued at $2,828,000 after acquiring an additional 2,536 shares in the last quarter. Axecap Investments LLC bought a new position in shares of CVS Health in the third quarter worth about $2,814,000. Carnegie Investment Counsel boosted its stake in shares of CVS Health by 3.6% in the third quarter. Carnegie Investment Counsel now owns 39,461 shares of the pharmacy operator’s stock worth $3,381,000 after acquiring an additional 1,357 shares during the period. Finally, Robeco Institutional Asset Management B.V. boosted its stake in shares of CVS Health by 4.1% in the third quarter. Robeco Institutional Asset Management B.V. now owns 2,091,736 shares of the pharmacy operator’s stock worth $179,241,000 after acquiring an additional 82,976 shares during the period. Institutional investors own 80.66% of the company’s stock.

Key CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS is expanding access through smaller, pharmacy-focused store formats in underserved communities. The strategy is intended to align locations with prescription demand, improve operating efficiency and support pharmacy growth. How Small Pharmacy Expansion Will Impact CVS Health Investors
• Positive Sentiment: MinuteClinic opened three new Massachusetts locations, including the first in Boston, broadening CVS’s retail healthcare footprint and potentially increasing patient traffic and service revenue. MinuteClinic Opens Three New Retail Medical Clinics
• Positive Sentiment: CVS is seeking to capture customers from Walgreens and Rite Aid as competitors close stores. The opportunity could support prescription volumes and strengthen CVS’s local market share. CVS Targets Former Walgreens and Rite Aid Customers
• Positive Sentiment: Aetna is streamlining prior authorizations, reporting that more than 95% of eligible requests are approved within 24 hours. Faster approvals may improve member experience and reduce administrative friction, although the direct financial effect is not yet quantified. How CVS Aetna Is Reducing Administrative Burden

CVS Health Stock Performance

NYSE CVS opened at $93.62 on Thursday. The company has a market cap of $119.74 billion, a P/E ratio of 24.77, a P/E/G ratio of 0.88 and a beta of 0.60. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. The business’s 50 day moving average price is $91.68 and its 200-day moving average price is $93.63. CVS Health Corporation has a fifty-two week low of $69.51 and a fifty-two week high of $110.68.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The firm had revenue of $106.10 billion during the quarter, compared to analyst estimates of $100.03 billion. During the same quarter last year, the business earned $1.81 EPS. The business’s revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Sell-side analysts predict that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd will be given a dividend of $0.6650 per share. The ex-dividend date of this dividend is Thursday, October 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 2.8%. CVS Health’s payout ratio is 70.37%.

Analysts Set New Price Targets

CVS has been the subject of a number of research analyst reports. Wells Fargo & Company increased their price objective on shares of CVS Health from $103.00 to $123.00 and gave the company an “overweight” rating in a report on Monday, July 13th. Weiss Ratings downgraded shares of CVS Health from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, October 9th. Truist Financial boosted their target price on shares of CVS Health from $108.00 to $118.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. HSBC restated a “hold” rating and set a $103.00 target price on shares of CVS Health in a research report on Monday, July 6th. Finally, Royal Bank Of Canada raised their target price on shares of CVS Health from $107.00 to $113.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Twenty investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $107.80.

CVS Health Profile

CVS Health Corporation (NYSE: CVS) is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.

The company’s Pharmacy Services segment, led by CVS Caremark, manages prescription drug benefits for employers, insurers and government programs. CVS Pharmacy operates retail pharmacies and health-focused stores that dispense prescriptions and offer over-the-counter products, health and wellness merchandise, immunizations and related services.